AG
ETRM

Advisor Group’s EnteroMedics Inc. ETRM Stock Holding History

Advisor Group’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2
Closed – – 4864
2016
Q3 		$0 Hold
2
– – ﹤0.01% 4882
2016
Q2 		$0 Buy
+2
New +$92 ﹤0.01% 4676

Other funds holding ETRM

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Advisor Group's ETRM Position: Q4 2016 in Review

Advisor Group sold out of EnteroMedics Inc. (ETRM) in Q4 2016, closing a stake of 2 shares.

Advisor Group first reported a position in ETRM in Q2 2016 and held it in 2 quarters. The position peaked at $0 in Q3 2016. 18 funds tracked by Wall St. Rank hold ETRM as of Q4 2016.

  • Advisor Group reported no remaining EnteroMedics Inc. position as of Q4 2016 after selling out during the quarter.
  • Advisor Group sold 2 EnteroMedics Inc. shares in Q4 2016.
  • Advisor Group first reported a position in EnteroMedics Inc. in Q2 2016 and held it in 2 quarters.
  • Advisor Group's EnteroMedics Inc. position peaked at $0 in Q3 2016.
  • 18 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2016.

Based on Advisor Group's 13F filing for Q4 2016, filed 31 Jan 2017.